Appraisal of Hepatic Resection in the Treatment of Hepatocellular Carcinoma with Severe Thrombocytopenia

Background Hepatic resection for hepatocellular carcinoma (HCC) patients with liver cirrhosis and severe hypersplenic thrombocytopenia is risky and controversial.